R C Moellering

发表论文 79 篇 · 总被引 4428 次 · h-index 34

代表论文

• The Rationale for Revising the Clinical and Laboratory Standards Institute Vancomycin Minimal Inhibitory Concentration Interpretive Criteria for Staphylococcus aureus (2007 · Clinical Infectious Diseases · 被引 456)
• Outbreak of ceftazidime resistance caused by extended-spectrum beta-lactamases at a Massachusetts chronic-care facility (1990 · Antimicrobial Agents and Chemotherapy · 被引 381)
• Increasing resistance to beta-lactam antibiotics among clinical isolates of Enterococcus faecium: a 22-year review at one institution (1991 · Antimicrobial Agents and Chemotherapy · 被引 197)
• In vitro and in vivo activity of LY 146032, a new cyclic lipopeptide antibiotic (1986 · Antimicrobial Agents and Chemotherapy · 被引 175)
• In vitro activity of CP-99,219, a new fluoroquinolone, against clinical isolates of gram-positive bacteria (1993 · Antimicrobial Agents and Chemotherapy · 被引 135)
• Editorial: Monitoring Serum Vancomycin Levels: Climbing the Mountain Because It Is There? (1994 · Clinical Infectious Diseases · 被引 123)